Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4199]

SABCS 2012: HDAC inhibitors sensitised triple-negative breast cancer cells to PARP inhibition and cisplatin treatment

SABCS 2012: HDAC inhibitors sensitised triple-negative breast cancer cells to PARP inhibition and cisplatin...

SABCS 2012: Diverse genetic alterations found in triple-negative breast cancers after neoadjuvant chemotherapy

SABCS 2012: Diverse genetic alterations found in triple-negative breast cancers after neoadjuvant chemotherapy

SABCS 2012: Young women with breast cancer were more likely than older women to respond to neoadjuvant chemotherapy

SABCS 2012: Young women with breast cancer were more likely than older women to respond to neoadjuvant chemotherapy

SABCS 2012: Chemotherapy after complete surgical removal of local or regional breast cancer recurrence increased survival rates

SABCS 2012: Chemotherapy after complete surgical removal of local or regional breast cancer recurrence increased...

SABCS 2012: Study confirms fewer, bigger doses of radiotherapy benefit cancer patients

SABCS 2012: Study confirms fewer, bigger doses of radiotherapy benefit cancer patients

SABCS 2012: Black women less likely to receive improved surgical procedure for breast cancer

SABCS 2012: Black women less likely to receive improved surgical procedure for breast cancer

SABCS 2012: Extending duration of adjuvant tamoxifen treatment to 10 years reduced risk for late breast cancer recurrence, improved survival

SABCS 2012: Extending duration of adjuvant tamoxifen treatment to 10 years reduced risk for late breast cancer...

SABCS 2012: Sentinel lymph node surgery after chemotherapy demonstrated accuracy in nodal staging for certain patients with breast cancer

SABCS 2012: Sentinel lymph node surgery after chemotherapy demonstrated accuracy in nodal staging for certain...

SABCS 2012: Combination of investigational agent and letrozole demonstrated clinical benefit in advanced ER-positive breast cancer

SABCS 2012: Combination of investigational agent and letrozole demonstrated clinical benefit in advanced ER...

SABCS 2012: Higher doses of fulvestrant prolonged survival in patients with advanced breast cancer

SABCS 2012: Higher doses of fulvestrant prolonged survival in patients with advanced breast cancer

More from ecancer